We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-3.51%
1 Year Est. Return
+28.4%
3 Year Est. Return
+87.65%
5 Year Est. Return
10 Year Est. Return
AUM
$975M
AUM Growth
-$56.8M
Cap. Flow
-$5.68M
Cap. Flow %
-0.58%
Top 10 Hldgs %
35.66%
Holding
694
New
35
Increased
143
Reduced
163
Closed
20

Top Buys

Rank Stock Value
1
CHWY icon
Chewy
CHWY
+$2.15M
2
BEPC icon
Brookfield Renewable
BEPC
+$1.38M
3
RMD icon
ResMed
RMD
+$1.24M
4
CSW
CSW Industrials
CSW
+$832K
5
BN icon
Brookfield
BN
+$650K

Top Sells

Rank Stock Value
1
PWR icon
Quanta Services
PWR
+$2.51M
2
PANW icon
Palo Alto Networks
PANW
+$1.25M
3
AAPL icon
Apple
AAPL
+$1.1M
4
NVDA icon
NVIDIA
NVDA
+$1.03M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$966K

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Healthcare 16%
3 Industrials 12.66%
4 Consumer Discretionary 12.07%
5 Communication Services 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONA icon
626
Liberty Media Series A
FWONA
$23.4B
$2.54K ﹤0.01%
45
+21
+88% +$1.28K
NEO icon
627
NeoGenomics
NEO
$1.96B
$2.51K ﹤0.01%
204
BRDG
628
DELISTED
Bridge Investment Group
BRDG
$2.48K ﹤0.01%
270
NE icon
629
Noble Corp
NE
$6.55B
$2.46K ﹤0.01%
+49
New +$2.5K
EG icon
630
Everest Group
EG
$15.6B
$2.46K ﹤0.01%
+7
New +$2.54K
HIMS icon
631
Hims & Hers Health
HIMS
$5.79B
$2.41K ﹤0.01%
383
CCK icon
632
Crown Holdings
CCK
$13B
$2.33K ﹤0.01%
+26
New +$2.33K
PTCT icon
633
PTC Therapeutics
PTCT
$6.18B
$2.31K ﹤0.01%
103
-41
-28% -$1.52K
CBAY
634
DELISTED
Cymabay Therapeutics
CBAY
$2.28K ﹤0.01%
+153
New +$2.03K
CAVA icon
635
CAVA Group
CAVA
$7.61B
$2.17K ﹤0.01%
+71
New +$3.1K
ALKT icon
636
Alkami Technology
ALKT
$1.96B
$2.08K ﹤0.01%
114
PODD icon
637
Insulet
PODD
$11.8B
$2.07K ﹤0.01%
13
-30
-70% -$6.72K
EVBG
638
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.07K ﹤0.01%
92
+8
+10% +$206
LLYVK icon
639
Liberty Live Group Series C
LLYVK
$9.54B
$2.06K ﹤0.01%
+64
New +$2.12K
APGE icon
640
Apogee Therapeutics
APGE
$10.1B
$2.04K ﹤0.01%
+96
New +$2.12K
NYC
641
American Strategic Investment Co
NYC
$30.4M
$2.04K ﹤0.01%
224
MRVI icon
642
Maravai LifeSciences
MRVI
$972M
$2.01K ﹤0.01%
201
+32
+19% +$351
ODD icon
643
ODDITY Tech
ODD
$690M
$1.99K ﹤0.01%
+70
New +$2.96K
U icon
644
Unity
U
$14B
$1.98K ﹤0.01%
63
AVPT icon
645
AvePoint
AVPT
$2.76B
$1.91K ﹤0.01%
284
-255
-47% -$1.61K
KRTX
646
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.86K ﹤0.01%
11
LBTYA icon
647
Liberty Global Class A
LBTYA
$3.59B
$1.75K ﹤0.01%
+102
New +$1.84K
LUNG icon
648
Pulmonx
LUNG
$52.8M
$1.73K ﹤0.01%
167
IXUS icon
649
iShares Core MSCI Total International Stock ETF
IXUS
$56.8B
$1.68K ﹤0.01%
28
MRTX
650
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.66K ﹤0.01%
38

Similar funds

Washington Trust Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Washington Trust Advisors held 694 positions worth $975M, down 5.5% from $1.03B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Washington Trust Advisors's Q3 2023 filing shows 35 new, 143 increased, 163 reduced and 20 closed positions. Its largest new stake was Penumbra: 2,071 shares worth $501K. The largest sale was Quanta Services, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Washington Trust Advisors's largest Q3 2023 buy was Penumbra: 2,071 shares worth $501K.
  • Washington Trust Advisors added most to Chewy in Q3 2023, an estimated $2.15M increase.
  • Washington Trust Advisors's biggest Q3 2023 reduction was Quanta Services, cutting an estimated $2.51M.
  • Washington Trust Advisors fully exited VanEck Long Muni ETF in Q3 2023, selling an estimated $153K.
  • Washington Trust Advisors's ten largest holdings make up 36% of its $975M portfolio in Q3 2023.
  • Washington Trust Advisors opened 35 new positions and closed 20 in Q3 2023.
  • Washington Trust Advisors's portfolio value fell 5.5% quarter-over-quarter to $975M.

Based on Washington Trust Advisors's 13F filing for Q3 2023, filed 18 Oct 2023.